نتائج البحث - Panagiotis A. Konstantinopoulos

تنقيح النتائج
  1. 1
    From checkpoint to checkpoint: DNA damage ATR/Chk1 checkpoint signalling elicits PD-L1 immune checkpoint activation

    From checkpoint to checkpoint: DNA damage ATR/Chk1 checkpoint signalling elicits PD-L1 immune checkpoint activation حسب Kent W. Mouw, Panagiotis A. Konstantinopoulos

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    PARP inhibition and immune modulation: scientific rationale and perspectives for the treatment of gynecologic cancers

    PARP inhibition and immune modulation: scientific rationale and perspectives for the treatment of gynecologic cancers حسب Elizabeth K. Lee, Panagiotis A. Konstantinopoulos

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair

    PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair حسب Panagiotis A. Konstantinopoulos, Stéphanie Lheureux, Kathleen N. Moore

    منشور في 2020
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis

    Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis حسب Michalis V. Karamouzis, Panagiotis A. Konstantinopoulos, Athanasios G. Papavassiliou

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Choosing wisely: Selecting PARP inhibitor combinations to promote anti-tumor immune responses beyond BRCA mutations

    Choosing wisely: Selecting PARP inhibitor combinations to promote anti-tumor immune responses beyond BRCA mutations حسب Jennifer Veneris, Ursula A. Matulonis, Joyce F. Liu, Panagiotis A. Konstantinopoulos

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer

    Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer حسب Panagiotis A. Konstantinopoulos, Andrew J. Wilson, Jeanette Saskowski, Erica Wass, Dineo Khabele

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer

    Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer حسب Panagiotis A. Konstantinopoulos, Raphaël Ceccaldi, Geoffrey I. Shapiro, Alan D. D’Andrea

    منشور في 2015
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Biomarkers of Response and Resistance to DNA Repair Targeted Therapies

    Biomarkers of Response and Resistance to DNA Repair Targeted Therapies حسب Elizabeth H. Stover, Panagiotis A. Konstantinopoulos, Ursula A. Matulonis, Elizabeth M. Swisher

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    DNA Damage and Repair Biomarkers of Immunotherapy Response

    DNA Damage and Repair Biomarkers of Immunotherapy Response حسب Kent W. Mouw, Michael S. Goldberg, Panagiotis A. Konstantinopoulos, Alan D. D’Andrea

    منشور في 2017
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Evolutionarily conserved serum microRNAs predict radiation-induced fatality in nonhuman primates

    Evolutionarily conserved serum microRNAs predict radiation-induced fatality in nonhuman primates حسب Wojciech Fendler, Beata Małachowska, Khyati Meghani, Panagiotis A. Konstantinopoulos, Chandan Guha, Vijay K. Singh, Dipanjan Chowdhury

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)

    Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001) حسب Panagiotis A. Konstantinopoulos, William E. Brady, John Farley, Amy E. Armstrong, Denise Uyar, David M. Gershenson

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Targeted Next-Generation Sequencing Reveals Clinically Actionable <i>BRAF</i> and <i>ESR1</i> Mutations in Low-Grade Serous Ovarian Carcinoma

    Targeted Next-Generation Sequencing Reveals Clinically Actionable <i>BRAF</i> and <i>ESR1</i> Mutations in Low-Grade Serous Ovarian Carcinoma حسب Elizabeth H. Stover, Colleen M. Feltmate, Ross S. Berkowitz, Neal I. Lindeman, Ursula A. Matulonis, Panagiotis A. Konstantinopoulos

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    MicroRNAs down-regulate homologous recombination in the G1 phase of cycling cells to maintain genomic stability

    MicroRNAs down-regulate homologous recombination in the G1 phase of cycling cells to maintain genomic stability حسب Young Eun Choi, Yunfeng Pan, Eunmi Park, Panagiotis A. Konstantinopoulos, Subhajyoti De, Alan D. D’Andrea, Dipanjan Chowdhury

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Resistance to therapy in <i>BRCA2</i> mutant cells due to loss of the nucleosome remodeling factor CHD4

    Resistance to therapy in <i>BRCA2</i> mutant cells due to loss of the nucleosome remodeling factor CHD4 حسب Shawna Guillemette, Ryan W. Serra, Min Peng, Janelle A. Hayes, Panagiotis A. Konstantinopoulos, Michael R. Green, Sharon B. Cantor

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer

    Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer حسب Panagiotis A. Konstantinopoulos, Dimitrios Spentzos, Elena Fountzilas, Nancy Francoeur, Srisowmya Sanisetty, Alexandros P. Grammatikos, Jonathan L. Hecht, Stephen A. Cannistra

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Gene Expression Profile of <i>BRCA</i>ness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer

    Gene Expression Profile of <i>BRCA</i>ness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer حسب Panagiotis A. Konstantinopoulos, Dimitrios Spentzos, Beth Y. Karlan, Toshiyasu Taniguchi, Elena Fountzilas, Nancy Francoeur, Douglas A. Levine, Stephen A. Cannistra

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    PARP Inhibition Induces Enrichment of DNA Repair–Proficient CD133 and CD117 Positive Ovarian Cancer Stem Cells

    PARP Inhibition Induces Enrichment of DNA Repair–Proficient CD133 and CD117 Positive Ovarian Cancer Stem Cells حسب Chiara Bellio, Celeste M. DiGloria, Rosemary Foster, Kaitlyn E. James, Panagiotis A. Konstantinopoulos, Whitfield B. Growdon, Bo R. Rueda

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    A Unique Subset of Epithelial Ovarian Cancers with Platinum Sensitivity and PARP Inhibitor Resistance

    A Unique Subset of Epithelial Ovarian Cancers with Platinum Sensitivity and PARP Inhibitor Resistance حسب Raphaël Ceccaldi, Kevin W. O’Connor, Kent W. Mouw, Adam Y. Li, Ursula A. Matulonis, Alan D. D’Andrea, Panagiotis A. Konstantinopoulos

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells

    Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells حسب Young Eun Choi, Chiara Battelli, Jacqueline Watson, Joyce F. Liu, Jennifer Curtis, Alexander Morse, Ursula A. Matulonis, Dipanjan Chowdhury, Panagiotis A. Konstantinopoulos

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Complications of pelvic radiation in patients treated for gynecologic malignancies

    Complications of pelvic radiation in patients treated for gynecologic malignancies حسب Akila N. Viswanathan, Larissa J. Lee, Jairam R. Eswara, Neil S. Horowitz, Panagiotis A. Konstantinopoulos, Kristina Mirabeau-Beale, Brent S. Rose, Arvind von Keudell, Jennifer Y. Wo

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: